World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
71785
World Ranking
4630
National Ranking
252

Overview

Ulrich Laufs is affiliated with Saarland University in Germany and has a significant research presence in the field of medicine, particularly focusing on cardiology and cardiovascular medicine. Their work spans diverse subfields including surgery, molecular biology, economics and econometrics, and endocrinology, diabetes, and metabolism.

The primary research topics explored by Laufs cover lipoproteins and cardiovascular health, diabetes combined with cardiovascular risks and lipoproteins, health systems and related economic evaluations, cancer concerning lipids and metabolism, atrial fibrillation management and outcomes, cardiovascular function and risk factors, as well as heart failure treatment and management.

Laufs has authored numerous papers published in several respected academic journals. Some of the recent publications include:

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel (2020) in European Heart Journal
  • Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis (2020) in Journal of Hepatology
  • Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity (2020) in Clinical Research in Cardiology
  • Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) (2021) in The Lancet
  • Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study (2023) in The Lancet Regional Health - Europe

Frequent coauthors who have collaborated extensively with Laufs include Jes-Niels Boeckel, Julius L. Katzmann, Rolf Wachter, Andreas Hagendorff, and Alberico L. Catapano.

The researcher has contributed repeatedly to prominent publication venues such as European Heart Journal, Atherosclerosis, Clinical Research in Cardiology, Circulation, and ESC Heart Failure, reflecting a sustained focus on cardiovascular medicine topics.

Best Publications

  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

    François Mach;Colin Baigent;Alberico L Catapano;Konstantinos C Koskinas

  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

    A Halliday;C Baigent;F Mach;B Mihaylova;B Mihaylova

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray

  • Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors

    U. Laufs;V. La Fata;J. Plutzky;J. K. Liao

  • PLEIOTROPIC EFFECTS OF STATINS

    James K. Liao;Ulrich Laufs

  • Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase

    Ulrich Laufs;James K. Liao

  • Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Jan Borén;M. John Chapman;M. John Chapman;Ronald M. Krauss;Chris J. Packard

  • Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

    Matthias Endres;Ulrich Laufs;Zhihong Huang;Tadashi Nakamura

  • Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis

    Ulrich Laufs;Nikos Werner;Andreas Link;Matthias Endres

  • Pleiotropic Effects of Statins on the Cardiovascular System.

    Adam Oesterle;Ulrich Laufs;James K. Liao

  • Intravenous Transfusion of Endothelial Progenitor Cells Reduces Neointima Formation After Vascular Injury

    Nikos Werner;Stefan Junk;Ulrich Laufs;Andreas Link

  • Cellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo

    Sven Wassmann;Ulrich Laufs;Kirsten Müller;Christian Konkol

  • HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen Species

    Sven Wassmann;Ulrich Laufs;Anselm T. Bäumer;Kirsten Müller

  • Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes

    Christopher Heeschen;Christian W. Hamm;Ulrich Laufs;Steven Snapinn

  • Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased Activity of Rac1-GTPase and Represents a Target for Statin Treatment

    Christoph Maack;Tanja Kartes;Heiko Kilter;Hans-Joachim Schäfers

  • Bone Marrow–Derived Progenitor Cells Modulate Vascular Reendothelialization and Neointimal Formation: Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition

    Nikos Werner;Josef Priller;Ulrich Laufs;Matthias Endres

  • Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension

    Felix Mahfoud;Bodo Cremers;Julia Janker;Britta Link

  • 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1).

    Ulrich Laufs;Diego Marra;Koichi Node;James K. Liao

  • Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants with Risk of Coronary Heart Disease

    Brian A. Ference;Brian A. Ference;John J.P. Kastelein;Kausik K. Ray;Henry N. Ginsberg

Frequent Co-Authors

Michael Böhm
Michael Böhm Saarland University
Winfried März
Winfried März Medical University of Graz
Dieter Lütjohann
Dieter Lütjohann University Hospital Bonn
Matthias Endres
Matthias Endres Charité - University Medicine Berlin
James K. Liao
James K. Liao University of Chicago
Georg Nickenig
Georg Nickenig University of Bonn
Ulf Landmesser
Ulf Landmesser Charité - University Medicine Berlin
Marcus E. Kleber
Marcus E. Kleber Heidelberg University
Hans-Joachim Schäfers
Hans-Joachim Schäfers Saarland University
Alberico L. Catapano
Alberico L. Catapano University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in a career in Medicine but aren’t ready for medical school, there are a variety of online nursing and healthcare programs that offer flexible study options and strong career prospects. Online degrees can be an ideal pathway for working professionals or those balancing other commitments.

For aspiring nurse practitioners, check out the most affordable nurse practitioner programs. These programs prepare you for advanced roles in patient care and leadership. Registered nurses looking to earn their bachelor's degree can explore the cheapest online bsn programs for a cost-effective way to grow their skills and job opportunities.

If you’re seeking entry-level qualifications, the cheapest online nursing programs offer accessible pathways to the nursing profession. For those interested in nursing research or academic roles, high-quality phd nursing programs online are available at affordable rates.

Exploring these related online degrees can help you start or advance your healthcare career, even if your ultimate goal is studying Medicine in the USA.

Best Scientists Citing Ulrich Laufs

Trending Scientists